# Simultaneous Quantification of Liver Fat Content, Fatty Acid Composition, and Fibrosis Using Spin-lock MRI for Steatohepatitis Assessment

> **NCT05384652** · — · ACTIVE_NOT_RECRUITING · sponsor: **Chinese University of Hong Kong** · enrollment: 140 (estimated)

## Conditions studied

- Non-alcoholic Fatty Liver Disease (NAFLD)
- Non-alcoholic Steatohepatitis (NASH)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05384652
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-01-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-06-30
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2026-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05384652

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05384652, "Simultaneous Quantification of Liver Fat Content, Fatty Acid Composition, and Fibrosis Using Spin-lock MRI for Steatohepatitis Assessment". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05384652. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*